If you could vote on Brexit now which option would you choose?
   

Eli Lilly says other COVID-19 antibody drug trials ongoing after study halted for safety concern


Eli Lilly & Co LLY.N on Wednesday said other trials of its experimental coronavirus antibody therapy remain on track after a government-run study testing the treatment in hospitalized COVID-19 patients was paused due to safety concerns. Lilly said on Tuesday that an independent safety monitoring board requested a pause in the trial, called ACTIV-3, due to a potential safety issue. The National Institutes of Health (NIH), which is collaborating with Lilly on the trial, said the advisory board paused the trial after seeing a “difference in clinical status” between patients on Lilly’s drug on those who received a placebo, without providing further detail.

Reuters - October 14, 2020

View the full story here: https://uk.reuters.com/article/us-health-coronavirus-eli-lilly-antibody/eli-lilly-says-other-covid-19-antibody-drug-trials-ongoing-after-study-halted-for-safety-concern-idUKKBN26Z21O